Research progress on occupational exposure risks and protective measures for medical personnel exposed to antineoplastic drugs

Abstract

Abstract: Due to the frequent clinical use of antineoplastic drugs,medical personnel who come into contact with antineoplastic drugs are at a greatly increased risk of exposure to contaminated environments. This paper reviews relevant literature at home and abroad to understand the occupational protection awareness of medical personnel who are currently exposed to antineoplastic drugs,and also summarizes the pathways,influencing factors and countermeasures of exposure to antineoplastic drugs,in order to enhance the attention of medical institutions and their management personnel to antineoplastic drugs exposure,improve the self-protection awareness of medical personnel,and provide reference for reducing damage caused by exposure to antineoplastic drugs.

Key words: Antineoplastic drugs, Occupational exposure, Medical personnel, Occupational protection

CLC Number:

R181.5⁺1

XIAO Qingqing, ZHOU Qian, HUANG Xiaohong. Research progress on occupational exposure risks and protective measures for medical personnel exposed to antineoplastic drugs. [J]OCCUPATION AND HEALTH, 2024, 40(11): 1577-1580.

References

[1] 卢培培,张楠,王家林.中国恶性肿瘤健康管理现状研究[J].中国公共卫生管理,2019,35(6):760-763.
[2] CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[3] 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,41(1):19-28.
[4] 中国肿瘤日间诊疗协作组.中国恶性肿瘤日间诊疗专家共识(2022版)[J].中华肿瘤杂志,2022,44(4):307-320.
[5] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[6] YADAV A,RENE E R,MANDAL M K,et al.Threat and sustainable technological solution for antineoplastic drugs pollution:Review on a persisting global issue[J].Chemosphere,2021,263:128285.
[7] HUANG X,GAO C,CAI W,et al.Effect of occupational exposure to antineoplastic drugs on DNA damage in nurses:A cross-sectional study[J].Occup Environ Med,2022,79(4):253-258.
[8] 苏毅馨,朱世杰,高业博,等.化疗相关心脏毒性问题研究进展[J].现代肿瘤医学,2022,30(17):3253-3256.
[9] 广东省药学会.铂类药物临床应用与不良反应管理专家共识[J].今日药学,2019,29(9):577-585.
[10] 梅小红,陈昌蕊,黄超,等.抗肿瘤药物对我国医务人员健康的影响及其防护研究进展[J].护理研究,2021,35(10):1766-1770.
[11] ACRAMEL A,BLONDEEL-GOMES S,MATTA C,et al.Reporting environmental contamination results to healthcare workers could play a crucial role in decreasing the risk of occupational exposure to antineoplastic drugs[J].Front Public Health,2022,10:989977.
[12] GERDING J,ANHAUSER L,EICKMANN U,et al.A simple approach to assess the cancer risk of occupational exposure to genotoxic drugs in healthcare settings[J].J Occup Med Toxicol,2022,17(1):8.
[13] 李佳,梅小红,陈昌蕊,等.铂类抗肿瘤药物遗传毒性和生殖毒性的研究进展[J].职业卫生与应急救援,2022,40(2):242-246.
[14] 郝梦琳,边原,周杨林,等.抗肿瘤药物职业暴露的研究进展[J].中国新药与临床杂志,2020,39(7):385-389.
[15] The National Institute for Occupational Safety and Health(NIOSH).Managing hazardous drug exposures:Information for healthcare settings[EB/OL].(2023-04-21).[2023-07-20].https://www.cdc.gov/niosh/docs/2023-130/.
[16] 国家卫生健康委办公厅.国家卫生健康委办公厅关于印发静脉用药调配中心建设与管理指南(试行)的通知[EB/OL].(2021-12-10).[2023-07-20].https://www.gov.cn/zhengce/zhengceku/2021-12/21/content_5663666.htm
[17] 职业健康司.关于印发国家职业病防治规划(2021—2025年)的通知[EB/OL].(2021-12-17).[2023-07-20].http://www.nhc.gov.cn/zyjks/s7786/202112/0aab1083f4e94d199312f22ffc2a6ce6.shtml.
[18] 朱玉蓉,龙欣,王政,等.陕西省医护人员的危害药品职业暴露及相关认知水平调查研究[J].中国药房,2020,31(7):869-872.
[19] 王鹏,符一岚,李沁璇,等.湖南省医疗机构工作人员抗肿瘤药物职业暴露调查分析[J].肿瘤药学,2023,13(2):233-240.
[20] 郝梦琳,边原,朱九群,等.四川省医务人员抗肿瘤药职业暴露调查分析[J].中国药房,2020,31(8):1009-1014.
[21] 强万敏,李苗苗.抗肿瘤药物职业暴露风险评估与安全管理的研究进展[J].中国护理管理,2023,23(1):12-16.
[22] 裴娜,刘延贤.化疗药物对医务人员职业危害与防护措施的评价研究[J].智慧健康,2022,8(1):179-181.
[23] 梅小红,张艳芳,林怡然,等.医护人员职业接触抗肿瘤药物的环境暴露评估[J].中国预防医学杂志,2022,23(11):845-850.
[24] 国家药品监督管理局.关于印发《医疗机构药品监督管理办法(试行)》的通知[EB/OL].(2011-10-11).[2023-07-21].https://www.nmpa.gov.cn/directory/web/nmpa/xxgk/fgwj/gzwj/gzwjyp/20111011103101334.html.
[25] 吕红梅,吴永佩.我国静脉用药集中调配模式的创建与现状[J].中国药房,2021,32(6):641-646.
[26] 李芸,沈国荣,张晶晶,等.我国10家医院静脉药物调配中心抗肿瘤药物环境污染评估及工作人员防护措施效果比较[J].中国医院药学杂志,2021,41(24):2591-2596.
[27] 黄运燕,李云霞,袁素娥.长沙市三级综合医院护理人员化疗职业防护现状调查[J].齐鲁护理杂志,2019,25(7):42-46.
[28] 李佳,梅小红,陈昌蕊,等.美国药典800章《危险药品-医疗保健环境中的处理标准》(2020版)解读[J].护理研究,2023,37(5):766-770.
[29] 孙妍,马骁驰,白荣,等.PIVAS建立对我院临床科室护理人员抗肿瘤药物职业暴露的防护作用调查[J].中国药房,2018,29(6):739-745.
[30] TANG Y,CHE X,WANG Y L,et al.Evaluation of closed system transfer devices in preventing chemotherapy agents contamination during compounding process-a single and comparative study in China[J].Front Public Health,2022,10:827835.
[31] U.S. Pharmacopeia.《800》Hazardous Drugs—Handling in Healthcare Settings[EB/OL].(2020-07-01).[2023-07-20].https://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare.
[32] 张峥,沈燕,于冬梅,等.导管室护士化疗职业防护现状调查[J].解放军护理杂志,2019,36(4):11-15.
[33] 郑晓峰,张薇,苏曼曼,等.徐州市三甲医院肿瘤专科护士化疗药物职业暴露现状[J].职业与健康,2018,34(9):1212-1216.
[34] FAZEL S S,KEEFE A,SHAREEF A,et al.Barriers and facilitators for the safe handling of antineoplastic drugs[J].J Oncol Pharm Pract,2022, 28(8):1709-1721.
[35] 邹东岑,徐帆.4种细胞毒性药物对不同材质手套的穿透性研究[J].华西药学杂志,2019,34(5):475-480.
[36] 丁建玲,李晓星,曹晓林.不同学习经历职业防护教育对护理人员抗肿瘤药物职业防护状况的影响[J].护理实践与研究,2017,14(21):117-119.
[37] 夏妍洁,朱斌.抗肿瘤药物规范化配制培训体系的建立与探讨[J].中国合理用药探索,2022,19(9):120-124.
[38] 陈佳茵,郭军,刘宁.护士职业暴露预防与管理的最佳证据总结[J].护理学报,2023,30(7):53-58.
[39] 侯洁,郝志英,段金菊.不同医院不同环境表面化疗药物污染情况调查[J].药物流行病学杂志,2018,27(1):49-52,57.
[40] 王会如,王霖,战玢.深度解析在用Ⅱ级生物安全柜现状[J].中国医疗器械信息,2019,25(5):43-47.
[42] Occupational Safety and Health Administration(OSHA).Controlling occupational exposure to hazardous drugs[EB/OL].(2019-02-12)[2023-09-09].https://www.osha.gov/hazardous-drugs/controlling-occex.
[43] 黄小红,李洋,黄超.非肿瘤科护士抗癌危害性药品暴露风险及健康管理[J].中国医院管理,2019,39(7):63-65.
[44] 包健安,沈国荣,王人英,等.多中心PIVAS集中调配人员抗肿瘤药物职业暴露评估[J].中国医院药学杂志,2016,36(9):701-706.
[45] 刘维,吴紫阳,杜冠华,等.《抗肿瘤药物暴露防护管理指南》解读[J].药物不良反应杂志,2023,25(3):133-137.